StockData

Amphastar Pharmaceuticals, Inc. (AMPH) income statement

AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3013% below fair value
$29.10−0.07 (-0.24%)

Close on Nov 17, 2026Market cap $1.24BP/E 17.1Yield –

Amphastar Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
47.7%
Operating margin
15.7%
Net margin
10.8%
Return on equity, FY2025
–

Financial strength

Current ratio
2.40
Debt to equity
–
Debt to assets
35.1%
Cash to current liabilities
85.0%

Valuation

P/E ratio
17.1
Price to sales
1.70
Price to book
–
Dividend yield
–

See a number that looks wrong?